The SDNY Patent Litigation Update provides a single-resource, monthly summary of patent litigation action in SDNY including complaints filed, important decisions, and trending issues. For example, last month Judge Scheindlin dismissed Medinol’s stent patent-infringement case against Cordis and J&J for laches. Read More >


More >

Date Filed

Case Number 



Patent Number(s)

Accused Product(s)



Pfizer Inc., Pfizer Limited, and Pfizer Ireland Pharmaceuticals

Torrent Pharmaceuticals Limited and Torrent Pharma Inc.


Generic version of Viagra(R)



Hunter Douglas, Inc.

Kohl's Corporation; Welcome Industrial Corp.


Top-Down/Bottom-Up Shades (window covering product)

Significant Decisions/Court Orders

More > 

Medinol Ltd v. Cordis Corporation et al
Case Number: 1:13-cv-01408-SAS
Date: March 14, 2014
Document (Dkt. 64)

Laches ends bifurcated stent patent infringement case

More >

Lexos Media, Inc. v. Zynga Inc.
Case Number: 1:12-cv-07994-PGG
Date: March 25, 2014
Document (Dkt. 97)

Speaking objections are not allowed, and neither are whispered instructions

More >

High Point Design LLC v. Buyers Direct Inc.
Case Number: 1:11-cv-04530
Date: March 26, 2014
Document (Dkt. 121)

The other shoe drops

More >


Topics:  Design Patent, Generic Drugs, Laches, Patent Infringement, Patent Litigation, Patents, Pfizer, Pharmaceutical Patents, Standing Objections

Published In: Civil Procedure Updates, Intellectual Property Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robins Kaplan LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »